Gefitinib Teva

Gefitinib Teva is an oral medication used for targeted therapy in cancer treatment. This pharmaceutical is designed to inhibit specific proteins that may contribute to cancer cell growth.

Gefitinib Teva is primarily used in the treatment of certain types of cancer. It works by targeting and inhibiting specific proteins that are involved in the growth and spread of cancer cells. This medication is often prescribed for patients with non-small cell lung cancer that has specific genetic markers. The drug is part of a class known as tyrosine kinase inhibitors, which are used to interfere with the growth of cancer cells.

Common effects of Gefitinib Teva may include skin rash, diarrhea, and nausea. Some patients may also experience fatigue or loss of appetite. These effects can vary in severity and may not affect everyone who takes the medication. It is important to discuss any persistent or severe side effects with a healthcare provider.

Gefitinib Teva should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should consult their healthcare provider before using this medication.

Gefitinib Teva may interact with certain medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or safety of the medication.